Peptide hair growth products are exposing the delivery problem
Peptide scalp care is gaining attention, but the harder work is topical route design, formulation stability, long-term use experience, and evidence.
Peptide hair growth products are exposing the delivery problem.
Recent public signals around peptide hair-growth serums point to a category moving from ingredient interest into product-development pressure. Cosmetics Business has been discussing how to formulate peptide hair growth serums. Kenvue brought dermatology research across hair and skin health to AAD 2026. KilgourMD has continued investing in clinical work and product pipelines.
Together, those signals make the next question more concrete. The market may keep talking about scalp growth peptides, but the development bottleneck is not simply which peptide to choose.
Scalp products have their own constraint set. They are used repeatedly, often over long periods, and directly on the scalp. A team has to think about topical route, vehicle, stability, residue, oiliness, irritation, hair feel, and user persistence. A product that is technically interesting but unpleasant to use will struggle to survive real behavior.
The active class also matters. Biotinoyl Tripeptide-1, GHK-Cu, minoxidil, and finasteride do not present the same formulation, penetration, solubility, stability, and risk questions. Treating them all as one “hair growth active” category can hide the specific delivery and evidence decisions each one requires.
For N1 Life, this is where peptide-enabled delivery becomes a practical product-development question. The relevant decision is not whether peptide language is marketable. It is whether the active can be delivered to the intended site, remain stable in a suitable formulation, support long-term use, and produce evidence that a partner can evaluate.
In scalp care, the next gap will not be between teams that mention peptides and teams that do not. It will be between teams that can make the route, formulation, use experience, and evidence work together, and teams that stop at the ingredient rationale.